Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Amarin Corporation PLC

AMRN
Current price
0.72 USD -0.036 USD (-4.77%)
Last closed 0.7 USD
Sector Healthcare
Industry Drug Manufacturers - General
Exchange NASDAQ
Capitalization 306 219 008 USD
Yield for 12 month -39.50 %
Week
Month
Year
AMRN
21.11.2021 - 28.11.2021

Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, European countries, Canada, Lebanon, and the United Arab Emirates. It offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally to wholesalers and specialty pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland. Address: Grand Canal Docklands, Dublin, Ireland, 2

Analytics

WallStreet Target Price

2.05 USD

P/E ratio

Dividend Yield

2.12 %

Current Year

+369 193 000 USD

Last Year

+583 187 000 USD

Current Quarter

+66 056 000 USD

Last Quarter

+80 167 000 USD

Current Year

+242 484 000 USD

Last Year

+461 860 000 USD

Current Quarter

+29 822 000 USD

Last Quarter

+42 668 000 USD

Key Figures AMRN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -19 554 000 USD
Operating Margin TTM -12.21 %
PE Ratio
Return On Assets TTM -1.61 %
PEG Ratio -1.74
Return On Equity TTM -9.2 %
Wall Street Target Price 2.05 USD
Revenue TTM 322 443 008 USD
Book Value 1.35 USD
Revenue Per Share TTM 0.79 USD
Dividend Share
Quarterly Revenue Growth YOY -26.5 %
Dividend Yield 2.12 %
Gross Profit TTM 260 562 000 USD
Earnings Share -0.12 USD
Diluted Eps TTM -0.12 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY -94.2 %
Profit Margin -16.27 %

Dividend Analytics AMRN

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History AMRN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield 2.12 %
Last Split Factor 1:10
Payout Ratio
Last Split Date 18.01.2008
Dividend Date

Stock Valuation AMRN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 500
Enterprise Value Revenue 0.4792
Price Sales TTM 0.9497
Enterprise Value EBITDA 0.0779
Price Book MRQ 0.5536

Financials AMRN

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators AMRN

For 52 weeks

0.65 USD 2.23 USD
50 Day MA 0.78 USD
Shares Short Prior Month 15 889 099
200 Day MA 1.17 USD
Short Ratio 9.25
Shares Short 15 319 946
Short Percent 3.77 %